{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T12:58:16Z","timestamp":1780664296319,"version":"3.54.1"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T00:00:00Z","timestamp":1775779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T00:00:00Z","timestamp":1775779200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hypertens Res"],"published-print":{"date-parts":[[2026,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Glucagon-like peptide-1 (GLP-1) receptor agonists are widely used to manage type 2 diabetes mellitus. However, there are reports indicating that patients administered GLP-1 receptor agonists often experience an increased heart rate. Although activation of the sympathetic nervous system may be involved in this response, the detailed mechanisms of action of GLP-1 receptor agonists are still not well understood. We hypothesized that GLP-1 receptor agonists could excite sympathetic nerve activity through direct effects on sympathetic-related neurons in the spinal cord and the medulla oblongata. Therefore, we examined the effects of a major GLP-1 receptor agonist, exendin-4, on sympathetic nerve activity at three different levels using in vitro preparations: (1) sympathetic nerve activity from the sympathetic nerve trunk, (2) preganglionic neurons in the intermediolateral cell column at the Th2\u20134 level of the spinal cord and (3) neurons in the rostral ventrolateral medulla corresponding to the C1 pressor area. Brainstem-spinal cord preparations were isolated from newborn rats (P0-P4) under deep isoflurane anesthesia and superfused with artificial cerebrospinal fluid, bubbled with 95% O\n                    <jats:sub>2<\/jats:sub>\n                    and 5% CO\n                    <jats:sub>2<\/jats:sub>\n                    at 25\u201326\u2009\u00b0C. We found that 20\u2013100\u2009nM exendin-4 induced an increase in sympathetic nerve activity and the effect was blocked by the application of a GLP-1 antagonist. The application of 100\u2009nM exendin-4 also induced membrane depolarization of the intermediolateral cell column and rostral ventrolateral medulla neurons. These results suggested that exendin-4 could induce increased sympathetic nerve activity via excitation of sympathetic-related neurons in the medulla and spinal cord.\n                  <\/jats:p>","DOI":"10.1038\/s41440-026-02633-5","type":"journal-article","created":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T07:30:16Z","timestamp":1775806216000},"page":"1939-1950","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["The effects of glucagon-like peptide-1 receptor agonists on sympathetic neuron activity"],"prefix":"10.1038","volume":"49","author":[{"given":"Yui","family":"Koyanagi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamon","family":"Iigaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiko","family":"Ikeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Onimaru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiko","family":"Izumizaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,10]]},"reference":[{"key":"2633_CR1","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.molmet.2019.09.010","volume":"30","author":"TD M\u00fcller","year":"2019","unstructured":"M\u00fcller TD, Finan B, Bloom SR, D\u2019Alessio D, Drucker DJ, Flatt PR, et al. Glucagon-like peptide 1 (GLP-1). Mol Metab. 2019;30:72\u2013130.","journal-title":"Mol Metab"},{"key":"2633_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2020.101024","volume":"39","author":"MK Holt","year":"2020","unstructured":"Holt MK, Cook DR, Brierley DI, Richards JE, Reimann F, Gourine AV, et al. PPG neurons in the nucleus of the solitary tract modulate heart rate but do not mediate GLP-1 receptor agonist-induced tachycardia in mice. Mol Metab. 2020;39:101024.","journal-title":"Mol Metab"},{"key":"2633_CR3","doi-asserted-by":"publisher","first-page":"R795","DOI":"10.1152\/ajpregu.00333.2015","volume":"309","author":"S Trapp","year":"2015","unstructured":"Trapp S, Cork SC. PPG neurons of the lower brain stem and their role in brain GLP-1 receptor activation. Am J Physiol Regul Integr Comp Physiol. 2015;309:R795\u2013804.","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"2633_CR4","doi-asserted-by":"publisher","first-page":"e2032232024","DOI":"10.1523\/JNEUROSCI.2032-23.2024","volume":"44","author":"XY Xu","year":"2024","unstructured":"Xu XY, Wang JX, Chen JL, Dai M, Wang YM, Chen Q, et al. GLP-1 in the hypothalamic paraventricular nucleus promotes sympathetic activation and hypertension. J Neurosci. 2024;44:e2032232024.","journal-title":"J Neurosci"},{"key":"2633_CR5","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s12933-016-0490-6","volume":"16","author":"M Lorenz","year":"2017","unstructured":"Lorenz M, Lawson F, Owens D, Raccah D, Roy-Duval C, Lehmann A, et al. Differential effects of glucagon-like peptide-1 receptor agonists on heart rate. Cardiovasc Diabetol. 2017;16:6.","journal-title":"Cardiovasc Diabetol"},{"key":"2633_CR6","first-page":"322","volume":"10","author":"B Rolek","year":"2023","unstructured":"Rolek B, Haber M, Gajewska M, Rogula S, Pietrasik A, Gasecka A. SGLT2 inhibitors vs. GLP-1 agonists to treat the heart, the kidneys and the brain. J Cardiovasc Dev Dis. 2023;10:322.","journal-title":"J Cardiovasc Dev Dis"},{"key":"2633_CR7","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1007\/s13340-025-00819-9","volume":"16","author":"Y Masuda","year":"2025","unstructured":"Masuda Y, Ohbayashi K, Iwasaki Y. Comparing the anorexigenic effects and mechanisms of gut-derived GLP-1 and its receptor agonists: insights into incretin-based therapies for obesity. Diabetol Int. 2025;16:448\u201356.","journal-title":"Diabetol Int"},{"key":"2633_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2021.109146","volume":"183","author":"Y Kawai","year":"2022","unstructured":"Kawai Y, Uneda K, Yamada T, Kinguchi S, Kobayashi K, Azushima K, et al. Comparison of effects of SGLT-2 inhibitors and GLP-1 receptor agonists on cardiovascular and renal outcomes in type 2 diabetes mellitus patients with\/without albuminuria: A systematic review and network meta-analysis. Diabetes Res Clin Pract. 2022;183:109146.","journal-title":"Diabetes Res Clin Pract"},{"key":"2633_CR9","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/S2213-8587(21)00203-5","volume":"9","author":"N Sattar","year":"2021","unstructured":"Sattar N, Lee MMY, Kristensen SL, Branch KRH, Del Prato S, Khurmi NS, et al. Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of randomised trials. Lancet Diabetes Endocrinol. 2021;9:653\u201362.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2633_CR10","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.124.037510","volume":"14","author":"T Kishimori","year":"2025","unstructured":"Kishimori T, Kato T, Wada A, Tani A, Yamaji R, Koike J, et al. Comparative outcomes of glucagon-like peptide-1 receptor agonists to dipeptidyl peptidase 4 inhibitors in patients with heart failure and type 2 diabetes. J Am Heart Assoc. 2025;14:e037510.","journal-title":"J Am Heart Assoc"},{"key":"2633_CR11","doi-asserted-by":"publisher","first-page":"e001986","DOI":"10.1136\/bmjopen-2012-001986","volume":"3","author":"LE Robinson","year":"2013","unstructured":"Robinson LE, Holt TA, Rees K, Randeva HS, O\u2019Hare JP. Effects of exenatide and liraglutide on heart rate, blood pressure and body weight: systematic review and meta-analysis. BMJ Open. 2013;3:e001986.","journal-title":"BMJ Open"},{"key":"2633_CR12","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1172\/JCI0215595","volume":"110","author":"H Yamamoto","year":"2002","unstructured":"Yamamoto H, Lee CE, Marcus JN, Williams TD, Overton JM, Lopez ME, et al. Glucagon-like peptide-1 receptor stimulation increases blood pressure and heart rate and activates autonomic regulatory neurons. J Clin Invest. 2002;110:43\u201352.","journal-title":"J Clin Invest"},{"key":"2633_CR13","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.nucmedbio.2016.04.002","volume":"43","author":"A Ryd\u00e9n","year":"2016","unstructured":"Ryd\u00e9n A, Nyman G, Nalin L, Andreasson S, Velikyan I, Korsgren O, et al. Corrigendum to \u201cCardiovascular side-effects and insulin secretion after intravenous administration of radiolabeled Exendin-4 in pigs\u201d. Nucl Med Biol. 2016;43:397\u2013402. 2016; 43(11): 742.","journal-title":"Nucl Med Biol"},{"key":"2633_CR14","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1111\/bcp.12843","volume":"81","author":"MM Smits","year":"2016","unstructured":"Smits MM, Muskiet MH, Tonneijck L, Hoekstra T, Kramer MH, Diamant M, et al. Exenatide acutely increases heart rate in parallel with augmented sympathetic nervous system activation in healthy overweight males. Br J Clin Pharmacol. 2016;81:613\u201320.","journal-title":"Br J Clin Pharmacol"},{"key":"2633_CR15","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1002\/ejhf.657","volume":"19","author":"A Jorsal","year":"2017","unstructured":"Jorsal A, Kistorp C, Holmager P, Tougaard RS, Nielsen R, H\u00e4nselmann A, et al. Effect of liraglutide, a glucagon-like peptide-1 analogue, on left ventricular function in stable chronic heart failure patients with and without diabetes (LIVE)-a multicentre, double-blind, randomised, placebo-controlled trial. Eur J Heart Fail. 2017;19:69\u201377.","journal-title":"Eur J Heart Fail"},{"key":"2633_CR16","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.neuroscience.2016.12.039","volume":"344","author":"N Oshima","year":"2017","unstructured":"Oshima N, Onimaru H, Matsubara H, Uchida T, Watanabe A, Imakiire T, et al. Direct effects of glucose, insulin, GLP-1, and GIP on bulbospinal neurons in the rostral ventrolateral medulla in neonatal wistar rats. Neuroscience. 2017;344:74\u201388.","journal-title":"Neuroscience"},{"key":"2633_CR17","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1007\/s12576-017-0549-5","volume":"67","author":"Y Oyama","year":"2017","unstructured":"Oyama Y, Iigaya K, Minoura Y, Okabe T, Izumizaki M, Onimaru H. An in vitro experimental model for analysis of central control of sympathetic nerve activity. J Physiol Sci. 2017;67:629\u201335.","journal-title":"J Physiol Sci"},{"key":"2633_CR18","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1038\/s41440-018-0049-x","volume":"41","author":"Y Minoura","year":"2018","unstructured":"Minoura Y, Onimaru H, Iigaya K, Kobayashi Y. Modulation of sympathetic preganglionic neuron activity via adrenergic receptors. Hypertens Res. 2018;41:499\u2013505.","journal-title":"Hypertens Res"},{"key":"2633_CR19","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1113\/jphysiol.1984.sp015370","volume":"354","author":"T Suzue","year":"1984","unstructured":"Suzue T. Respiratory rhythm generation in the in vitro brain stem-spinal cord preparation of the neonatal rat. J Physiol. 1984;354:173\u201383.","journal-title":"J Physiol"},{"key":"2633_CR20","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1002\/cne.902280204","volume":"228","author":"CA Ross","year":"1984","unstructured":"Ross CA, Ruggiero DA, Joh TH, Park DH, Reis DJ. Rostral ventrolateral medulla: selective projections to the thoracic autonomic cell column from the region containing C1 adrenaline neurons. J Comp Neurol. 1984;228:168\u201385.","journal-title":"J Comp Neurol"},{"key":"2633_CR21","doi-asserted-by":"publisher","first-page":"R187","DOI":"10.1152\/ajpregu.00054.2013","volume":"305","author":"PG Guyenet","year":"2013","unstructured":"Guyenet PG, Stornetta RL, Bochorishvili G, Depuy SD, Burke PG, Abbott SB. C1 neurons: the body\u2019s EMTs. Am J Physiol Regul Integr Comp Physiol. 2013;305:R187\u2013204.","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"2633_CR22","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/0006-8993(88)91508-9","volume":"442","author":"MK Sun","year":"1988","unstructured":"Sun MK, Young BS, Hackett JT, Guyenet PG. Reticulospinal pacemaker neurons of the rat rostral ventrolateral medulla with putative sympathoexcitatory function: an intracellular study in vitro. Brain Res. 1988;442:229\u201339.","journal-title":"Brain Res"},{"key":"2633_CR23","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/0006-8993(86)91198-4","volume":"377","author":"AR Granata","year":"1986","unstructured":"Granata AR, Numao Y, Kumada M, Reis DJ. A1 noradrenergic neurons tonically inhibit sympathoexcitatory neurons of C1 area in rat brainstem. Brain Res. 1986;377:127\u201346.","journal-title":"Brain Res"},{"key":"2633_CR24","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/0006-8993(85)90640-7","volume":"339","author":"DA Ruggiero","year":"1985","unstructured":"Ruggiero DA, Meeley MP, Anwar M, Reis DJ. Newly identified GABAergic neurons in regions of the ventrolateral medulla which regulate blood pressure. Brain Res. 1985;339:171\u20137.","journal-title":"Brain Res"},{"key":"2633_CR25","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1016\/0028-3908(83)90027-8","volume":"22","author":"RN Willette","year":"1983","unstructured":"Willette RN, Barcas PP, Krieger AJ, Sapru HN. Vasopressor and depressor areas in the rat medulla Identification by microinjection of L-glutamate. Neuropharmacology. 1983;22:1071\u20139.","journal-title":"Neuropharmacology"},{"key":"2633_CR26","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1007\/s00424-025-03077-5","volume":"477","author":"H Onimaru","year":"2025","unstructured":"Onimaru H, Koyanagi Y, Iigaya K, Ikeda K, Izumizaki M. Intrinsic responses to hypoxia and hypercapnia of neurons in the cardiorespiratory center of the ventral medulla of newborn rats. Pflugers Arch. 2025;477:685\u2013705.","journal-title":"Pflugers Arch"},{"key":"2633_CR27","doi-asserted-by":"publisher","first-page":"G1474","DOI":"10.1152\/ajpgi.00562.2006","volume":"292","author":"S Wan","year":"2007","unstructured":"Wan S, Coleman FH, Travagli RA. Glucagon-like peptide-1 excites pancreas-projecting preganglionic vagal motoneurons. Am J Physiol Gastrointest Liver Physiol. 2007;292:G1474\u201382.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"2633_CR28","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1021\/acs.jmedchem.6b01706","volume":"60","author":"KD Nance","year":"2017","unstructured":"Nance KD, Days EL, Weaver CD, Coldren A, Farmer TD, Cho HP, et al. Discovery of a novel series of orally bioavailable and CNS penetrant glucagon-like peptide-1 receptor (GLP-1R) noncompetitive antagonists based on a 1,3-disubstituted-7-aryl-5,5-bis(trifluoromethyl)-5,8-dihydropyrimido[4,5-d]pyrimidine-2,4(1H,3H)-dione core. J Med Chem. 2017;60:1611\u201316.","journal-title":"J Med Chem"},{"key":"2633_CR29","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1007\/BF00374476","volume":"420","author":"H Onimaru","year":"1992","unstructured":"Onimaru H, Homma I. Whole cell recordings from respiratory neurons in the medulla of brainstem-spinal cord preparations isolated from newborn rats. Pflugers Arch. 1992;420:399\u2013406.","journal-title":"Pflugers Arch"},{"key":"2633_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.resp.2021.103737","volume":"293","author":"S Katsuki","year":"2021","unstructured":"Katsuki S, Ikeda K, Onimaru H, Dohi K, Izumizaki M. Effects of acetylcholine on hypoglossal and C4 nerve activity in brainstem-spinal cord preparations from newborn rat. Respir Physiol Neurobiol. 2021;293:103737.","journal-title":"Respir Physiol Neurobiol"},{"key":"2633_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-65442-1","volume":"14","author":"Y Ruska","year":"2024","unstructured":"Ruska Y, Csibi A, Dorogh\u00e1zi B, Szilv\u00e1sy-Szab\u00f3 A, Moh\u00e1csik P, K\u00f6rnyei Z, et al. Topography of the GLP-1\/GLP-1 receptor system in the spinal cord of male mice. Sci Rep. 2024;14:14403.","journal-title":"Sci Rep"},{"key":"2633_CR32","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/S1566-0702(00)00179-X","volume":"84","author":"N Oshima","year":"2000","unstructured":"Oshima N, Kumagai H, Kawai A, Sakata K, Matsuura T, Saruta T. Three types of putative presympathetic neurons in the rostral ventrolateral medulla studied with rat brainstem-spinal cord preparation. Auton Neurosci. 2000;84:40\u20139.","journal-title":"Auton Neurosci"},{"key":"2633_CR33","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/0006-8993(91)90359-4","volume":"555","author":"J Minson","year":"1991","unstructured":"Minson J, Pilowsky P, Llewellyn-Smith I, Kaneko T, Kapoor V, Chalmers J. Glutamate in spinally projecting neurons of the rostral ventral medulla. Brain Res. 1991;555:326\u201331.","journal-title":"Brain Res"},{"key":"2633_CR34","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1002\/(SICI)1096-9861(19971103)387:4<524::AID-CNE4>3.0.CO;2-4","volume":"387","author":"AM Schreihofer","year":"1997","unstructured":"Schreihofer AM, Guyenet PG. Identification of C1 presympathetic neurons in rat rostral ventrolateral medulla by juxtacellular labeling in vivo. J Comp Neurol. 1997;387:524\u201336.","journal-title":"J Comp Neurol"},{"key":"2633_CR35","doi-asserted-by":"publisher","first-page":"22","DOI":"10.3390\/molecules22010022","volume":"22","author":"G Shaaban","year":"2016","unstructured":"Shaaban G, Oriowo M, Al-Sabah S. Rate of homologous desensitization and internalization of the GLP-1 receptor. Molecules. 2016;22:22.","journal-title":"Molecules"},{"key":"2633_CR36","first-page":"62","volume":"10","author":"C Widmann","year":"1996","unstructured":"Widmann C, Dolci W, Thorens B. Desensitization and phosphorylation of the glucagon-like peptide-1 (GLP-1) receptor by GLP-1 and 4-phorbol 12-myristate 13-acetate. Mol Endocrinol. 1996;10:62\u201375.","journal-title":"Mol Endocrinol"},{"key":"2633_CR37","doi-asserted-by":"publisher","first-page":"2583","DOI":"10.2147\/DMSO.S375559","volume":"15","author":"M Dong","year":"2022","unstructured":"Dong M, Wen S, Zhou L. The relationship between the blood-brain-barrier and the central effects of glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors. Diabetes Metab Syndr Obes. 2022;15:2583\u201397.","journal-title":"Diabetes Metab Syndr Obes"},{"key":"2633_CR38","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/S0196-9781(03)00059-7","volume":"24","author":"D Dogrukol-Ak","year":"2003","unstructured":"Dogrukol-Ak D, Banks WA, Tuncel N, Tuncel M. Passage of vasoactive intestinal peptide across the blood-brain barrier. Peptides. 2003;24:437\u201344.","journal-title":"Peptides"},{"key":"2633_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2024.109952","volume":"253","author":"C Holscher","year":"2024","unstructured":"Holscher C. Glucagon-like peptide-1 class drugs show clear protective effects in Parkinson\u2019s and Alzheimer\u2019s disease clinical trials: A revolution in the making?. Neuropharmacology. 2024;253:109952.","journal-title":"Neuropharmacology"},{"key":"2633_CR40","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1002\/(SICI)1096-9861(19990111)403:2<261::AID-CNE8>3.0.CO;2-5","volume":"403","author":"I Merchenthaler","year":"1999","unstructured":"Merchenthaler I, Lane M, Shughrue P. Distribution of pre-pro-glucagon and glucagon-like peptide-1 receptor messenger RNAs in the rat central nervous system. J Comp Neurol. 1999;403:261\u201380.","journal-title":"J Comp Neurol"},{"key":"2633_CR41","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/s00429-020-02189-1","volume":"226","author":"E Farkas","year":"2021","unstructured":"Farkas E, Szilv\u00e1sy-Szab\u00f3 A, Ruska Y, Sink\u00f3 R, Rasch MG, Egebjerg T, et al. Distribution and ultrastructural localization of the glucagon-like peptide-1 receptor (GLP-1R) in the rat brain. Brain Struct Funct. 2021;226:225\u201345.","journal-title":"Brain Struct Funct"},{"key":"2633_CR42","doi-asserted-by":"publisher","first-page":"2445","DOI":"10.1002\/cne.24905","volume":"528","author":"DL Graham","year":"2020","unstructured":"Graham DL, Durai HH, Trammell TS, Noble BL, Mortlock DP, Galli A, et al. A novel mouse model of glucagon-like peptide-1 receptor expression: A look at the brain. J Comp Neurol. 2020;528:2445\u201370.","journal-title":"J Comp Neurol"},{"key":"2633_CR43","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1016\/j.peptides.2005.02.016","volume":"26","author":"T Osaka","year":"2005","unstructured":"Osaka T, Endo M, Yamakawa M, Inoue S. Energy expenditure by intravenous administration of glucagon-like peptide-1 mediated by the lower brainstem and sympathoadrenal system. Peptides. 2005;26:1623\u201331.","journal-title":"Peptides"},{"key":"2633_CR44","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1093\/cvr\/cvq271","volume":"89","author":"KJ Griffioen","year":"2011","unstructured":"Griffioen KJ, Wan R, Okun E, Wang X, Lovett-Barr MR, Li Y, et al. GLP-1 receptor stimulation depresses heart rate variability and inhibits neurotransmission to cardiac vagal neurons. Cardiovasc Res. 2011;89:72\u20138.","journal-title":"Cardiovasc Res"},{"key":"2633_CR45","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1111\/j.1365-2125.2012.04214.x","volume":"74","author":"B Mendis","year":"2012","unstructured":"Mendis B, Simpson E, MacDonald I, Mansell P. Investigation of the haemodynamic effects of exenatide in healthy male subjects. Br J Clin Pharmacol. 2012;74:437\u201344.","journal-title":"Br J Clin Pharmacol"},{"key":"2633_CR46","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1210\/en.2018-00004","volume":"159","author":"LL Baggio","year":"2018","unstructured":"Baggio LL, Yusta B, Mulvihill EE, Cao X, Streutker CJ, Butany J, et al. GLP-1 receptor expression within the human heart. Endocrinology. 2018;159:1570\u201384.","journal-title":"Endocrinology"},{"key":"2633_CR47","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1210\/en.2013-1934","volume":"155","author":"C Pyke","year":"2014","unstructured":"Pyke C, Heller RS, Kirk RK, \u00d8rskov C, Reedtz-Runge S, Kaastrup P, et al. GLP-1 receptor localization in monkey and human tissue: novel distribution revealed with extensively validated monoclonal antibody. Endocrinology. 2014;155:1280\u201390.","journal-title":"Endocrinology"},{"key":"2633_CR48","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1093\/cvr\/cvae120","volume":"120","author":"AF Lubberding","year":"2024","unstructured":"Lubberding AF, Veedfald S, Achter JS, Nissen SD, Soattin L, Sorrentino A, et al. Glucagon-like peptide-1 increases heart rate by a direct action on the sinus node. Cardiovasc Res. 2024;120:1427\u201341.","journal-title":"Cardiovasc Res"},{"key":"2633_CR49","first-page":"E784","volume":"277","author":"JM Barrag\u00e1n","year":"1999","unstructured":"Barrag\u00e1n JM, Eng J, Rodr\u00edguez R, Bl\u00e1zquez E. Neural contribution to the effect of glucagon-like peptide-1-(7-36) amide on arterial blood pressure in rats. Am J Physiol. 1999;277:E784\u201391.","journal-title":"Am J Physiol"},{"key":"2633_CR50","doi-asserted-by":"publisher","first-page":"2050","DOI":"10.7150\/ijbs.59965","volume":"17","author":"X Ma","year":"2021","unstructured":"Ma X, Liu Z, Ilyas I, Little PJ, Kamato D, Sahebka A, et al. GLP-1 receptor agonists (GLP-1RAs): cardiovascular actions and therapeutic potential. Int J Biol Sci. 2021;17:2050\u201368.","journal-title":"Int J Biol Sci"},{"key":"2633_CR51","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/S0140-6736(21)00536-5","volume":"398","author":"E Brown","year":"2021","unstructured":"Brown E, Heerspink HJL, Cuthbertson DJ, Wilding JPH. SGLT2 inhibitors and GLP-1 receptor agonists: established and emerging indications. Lancet. 2021;398:262\u201376.","journal-title":"Lancet"},{"key":"2633_CR52","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/s41569-023-00849-3","volume":"20","author":"JR Ussher","year":"2023","unstructured":"Ussher JR, Drucker DJ. Glucagon-like peptide 1 receptor agonists: cardiovascular benefits and mechanisms of action. Nat Rev Cardiol. 2023;20:463\u201374.","journal-title":"Nat Rev Cardiol"},{"key":"2633_CR53","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1038\/s41392-024-01931-z","volume":"9","author":"Z Zheng","year":"2024","unstructured":"Zheng Z, Zong Y, Ma Y, Tian Y, Pang Y, Zhang C, et al. Glucagon-like peptide-1 receptor: mechanisms and advances in therapy. Signal Transd Target Ther. 2024;9:234.","journal-title":"Signal Transd Target Ther"},{"key":"2633_CR54","doi-asserted-by":"publisher","first-page":"3055","DOI":"10.1210\/jc.2003-031403","volume":"89","author":"JP Gutzwiller","year":"2004","unstructured":"Gutzwiller JP, Tschopp S, Bock A, Zehnder CE, Huber AR, Kreyenbuehl M, et al. Glucagon-like peptide 1 induces natriuresis in healthy subjects and in insulin-resistant obese men. J Clin Endocrinol Metab. 2004;89:3055\u201361.","journal-title":"J Clin Endocrinol Metab"},{"key":"2633_CR55","doi-asserted-by":"publisher","first-page":"E664","DOI":"10.1210\/jc.2012-3855","volume":"98","author":"J Skov","year":"2013","unstructured":"Skov J, Dejgaard A, Fr\u00f8ki\u00e6r J, Holst JJ, Jonassen T, Rittig S, et al. Glucagon-like peptide-1 (GLP-1): effect on kidney hemodynamics and renin-angiotensin-aldosterone system in healthy men. J Clin Endocrinol Metab. 2013;98:E664\u201371.","journal-title":"J Clin Endocrinol Metab"},{"key":"2633_CR56","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1007\/s11906-015-0621-6","volume":"18","author":"A Goud","year":"2016","unstructured":"Goud A, Zhong J, Peters M, Brook RD, Rajagopalan S. GLP-1 agonists and blood pressure: a review of the evidence. Curr Hypertens Rep. 2016;18:16.","journal-title":"Curr Hypertens Rep"},{"key":"2633_CR57","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1186\/s13098-023-01118-6","volume":"15","author":"M Yu","year":"2023","unstructured":"Yu M, Wang R, Pei L, Zhang X, Wei J, Wen Y, et al. The relationship between the use of GLP-1 receptor agonists and the incidence of respiratory illness: a meta-analysis of randomized controlled trials. Diabetol Metab Syndr. 2023;15:164.","journal-title":"Diabetol Metab Syndr"},{"key":"2633_CR58","doi-asserted-by":"publisher","first-page":"e071380","DOI":"10.1136\/bmj-2022-071380","volume":"379","author":"R Pradhan","year":"2022","unstructured":"Pradhan R, Lu S, Yin H, Yu OHY, Ernst P, Suissa S, et al. Novel antihyperglycaemic drugs and prevention of chronic obstructive pulmonary disease exacerbations among patients with type 2 diabetes: population based cohort study. BMJ. 2022;379:e071380.","journal-title":"BMJ"},{"key":"2633_CR59","doi-asserted-by":"publisher","DOI":"10.1210\/endocr\/bqae165","volume":"166","author":"S B\u00f6rchers","year":"2025","unstructured":"B\u00f6rchers S, Skibicka KP. GLP-1 and its analogs: does sex matter?. Endocrinology. 2025;166:bqae165.","journal-title":"Endocrinology"}],"container-title":["Hypertension Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41440-026-02633-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41440-026-02633-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41440-026-02633-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T22:02:34Z","timestamp":1780610554000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41440-026-02633-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,10]]},"references-count":59,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["2633"],"URL":"https:\/\/doi.org\/10.1038\/s41440-026-02633-5","relation":{},"ISSN":["0916-9636","1348-4214"],"issn-type":[{"value":"0916-9636","type":"print"},{"value":"1348-4214","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,10]]},"assertion":[{"value":"24 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 March 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no conflicts of interest in association with the present study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}